Form 4: Adagio Medical CEO Buys 207,315 Shares in Open Market

Adagio Medical Holdings, Inc. CEO Todd Usen acquired 207,315 shares of common stock in an open market purchase, signaling confidence in the company.

Summary

• Todd Usen, Chief Executive Officer and Director of Adagio Medical Holdings, Inc. (ADGM), purchased 207,315 shares of the company's common stock.
• The transaction occurred on December 12, 2025, and was an open market purchase.
• The shares were acquired at a weighted average price of $1.09 per share, with individual trades ranging from $0.9258 to $1.14101.
• This purchase was executed pursuant to a Rule 10b5-1(c) plan.
• Following this transaction, Todd Usen beneficially owns 207,315 shares of common stock.

Sentiment

Score: 8

Explanation: The sentiment is positive due to a significant insider purchase by the CEO, indicating strong confidence in the company's future performance and valuation.

Positives

• An insider purchase by the CEO and a Director, Todd Usen, demonstrates management's confidence in the company's future prospects and valuation.
• The acquisition of 207,315 shares represents a significant investment by a key executive.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

This insider transaction reflects an individual executive's belief in the company's value, which can be a positive signal for investors, especially in the medical device or healthcare technology sector where Adagio Medical operates. It does not, however, provide broader industry trend analysis.

Related Party Transactions

• The transaction involves Todd Usen, the Chief Executive Officer and a Director of Adagio Medical Holdings, Inc., purchasing shares of the company's common stock, which is a related party transaction.

Stakeholder Impact

• Shareholders may view this insider purchase as a positive indicator of management's confidence, potentially leading to increased investor interest and a positive impact on share price.

Key Dates

Recommendation

The significant open market purchase by the CEO and a Director, Todd Usen, signals strong insider confidence in Adagio Medical Holdings, Inc. This often suggests that management believes the company's stock is undervalued or that positive developments are on the horizon. Such a move by a key executive, especially when executed under a 10b5-1 plan, typically warrants a 'buy' recommendation for investors looking for companies with strong insider conviction.

Keywords

Adagio Medical Holdings, ADGM, Todd Usen, Insider Trading, Stock Purchase, CEO, Director, Common Stock, Rule 10b5-1